Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Trial: Page 3
Unilabs, Ambry Genetics to provide genetic testing for biopharma firms in Europe, Latin America, Middle East
The companies aim to address one of the main challenges to the use of genomics in global clinical trials: a lack of standardization in laboratory testing protocols and analysis.
January 26, 2023
After Illumina presentation highlighting Grail potential comes a possible EU fine
At the J.P. Morgan healthcare event this week, Illumina's CEO said Grail must be operated separately and independently pursuant to measures required by the EU.
January 12, 2023
OpGen to prepare FDA de novo request, completes clinical trial for UTI panel
The completed trial evaluated the performance of the Unyvero UTI Panel for detecting urinary tract infections using clean-catch or catheter-related urine samples.
December 13, 2022
BillionToOne announces clinical data on NIPT for recessive conditions
The firm's Unity Screen is designed to assess fetal risk of recessive conditions such as cystic fibrosis, sickle cell disease, the thalassemias, and spinal muscular atrophy.
December 6, 2022
Reveal Genomics presents trial results for HER2Dx breast cancer test at SABCS
The results show that an HER2Dx risk score was significantly associated with relapse-free interval and long-term survival outcomes; additionally, HER2Dx can identify patients who might be candidates for neoadjuvants or de-escalation of systemic therapy.
December 6, 2022
Diadem presents data at CTAD on blood test for early prediction of Alzheimer's
The firm is preparing to launch a test next year that enables drug developers to identify with high confidence individuals who will experience a decline to Alzheimer's dementia up to six years in advance of diagnosis.
December 5, 2022
Global Health Innovative Technology obtains $20M grant over five years from Wellcome
GHIT said that in 2023, the tenth anniversary of its founding, it will aim to streamline and accelerate research and development for malaria, tuberculosis, neglected tropical diseases, and other infectious diseases.
December 5, 2022
Blood-based MDx test developer DiamiR to present poster on trial findings at CTAD
The poster will be presented during the session “Clinical trials: Biomarkers including plasma” during the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco from November 29 to December 2.
November 28, 2022
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
The study, which will enroll more than 1,000 participants, aims to evaluate the noninvasive, qPCR assay which detects two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer.
November 23, 2022
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
SomaLogic touts NIH study of proteomic profiling platform
According to company, researchers conducting the study found that the platform demonstrates strength in proteome coverage and sensitivity, and it provides consistently low variability.
October 28, 2022
Previous Page
Page 3 of 17
Next Page